Loading company…
Milu Labs is a New York women's health company developing noninvasive tests for early detection of preterm birth.
Founded by Matthew Badalucco and based in New York, US, Milu Labs develops diagnostic solutions for women's health, including noninvasive tests that estimate the likelihood of preterm birth early in pregnancy. It is also developing diagnostic platforms that analyze proteome, transcriptome, epigenome and microbiome data. Its customers include hospitals, clinics and specialized healthcare facilities, mainly in North America and Europe. On March 7, 2019, the company raised seed funding led by Magna Investment.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in